DILATED CARDIOMYOPATHY: A MODERN VIEW OF DISEASE

Cover Page


Cite item

Full Text

Abstract

Dilated cardiomyopathy - the primary lesion of the myocardium due to various reasons, characterized by a pronounced expansion of the heart chambers and decreased systolic and diastolic functions. Among the etiological causes in the first place should include a genetic predisposition. Diagnosis of the disease involves the identification of specific changes in echocardiography and the exclusion of other causes of heart failure. Therapy is symptomatic. Questions such as prediction of disease, improved survival, pathogenetic therapy, still await solution.

Full Text

ДИЛАТАЦИОННАЯ КАРДИОМИОПАТИЯ: СОВРЕМЕННЫЙ ВЗГЛЯД НА ЗАБОЛЕВАНИЕ
×

References

  1. Болезни сердца и сосудов: руководство Европейского общества кардиологов: пер. с англ. / А. Джона Кэмм [и др.]; под ред. Е.В. Шляхто. - М.: ГЭОТАРМедиа, 2011. - 1789 с.
  2. Национальные рекомендации ВНОК И ОССН по диагностике и лечению ХСН (третий пересмотр) / В.Ю. Мареев [и др.] // Сердечная Недостаточность. - 2010. - Т. 11, №1 (57).
  3. Первые результаты российского эпидемиологического исследования по ХСН / Ю.Н. Беленков [и др.] // Сердечная Недостаточность. - 2003. - №4 (1). - С. 26-30.
  4. Руководство по неишемической кардиологии / Д.В. Абельдяев [и др.]; под ред. Н.А. Шостак. - М.: ГЭОТАР-Медиа, 2009.
  5. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia / S.A. Strickberger [et al.] // J. Am. Coll. Cardiol. - 2003. - Vol. 41. - P. 17071712.
  6. Bowles N.E. The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy / K.R. Bowles, J.A. Towbin // Herz. - 2000. -Vol. 25. - P. 168-175.
  7. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases / P. Elliott [et al.] // Eur. Heart. J. - 2008. -Vol. 29, № 2. - P. 270-276.
  8. Contemporary Definitions and Classification of the Cardiomyopathies. An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention / B.J. Maron [et al.] // Circulation. - 2006. - Vol. 113. -P. 1807-1816.
  9. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy / L. Mestroni [et al.] // Eur. Heart J. - 1999. - Vol. 20. - P. 93-102.
  10. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with CHF / T. Tsutamoto [et al.] // J. Am. Coll. Cardiol. - 1998. - Vol. 31. - P. 391-398.
  11. Lemos L.A. B-natriuretic peptide in cardiovascular disease / D.K. McGuire, M.H. Drazner // Lancet. - 2003. - Vol. 362. - P. 316-322.
  12. Mason J.W. Myocarditis and dilated cardiomyopathy: an inflammatory link / J.W. Mason // Cardiovasc. Res. - 2003. - Vol. 60. - P. 5-10.
  13. Non-invasive detection of myocardial ischemia from perfusion based on nuclear magnetic resonance / N. Al-Saadi [et al.] // Circulation. - 2000. - Vol. 101. -P. 1379-1383.
  14. Prognostic value of serial cardiac assessment and familial screening in patients with dilated cardiomyopathy / E. Grünig [et al.] // Eur. J. Heart Fail. - 2003. - Vol. 5. - P. 55-62.
  15. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial / S. Seth [et al.] // J Am Coll Cardiol. - 2006. - Vol. 48. - P. 2350-2351.
  16. Effects of Intracoronary CD34+ Stem Cell Transplantation in Nonischemic Dilated Cardiomyopathy Patients: 5-Year Follow-Up / B. Vrtovec [et al.] // Circ Res. - 2013. - Vol. 112, №1. - Р. 165-173.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Zotova L.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies